High Times
Home > Boards > US Listed > Medical - Drugs >

Apricus Biosciences, Inc. (APRI)

APRI RSS Feed
Add APRI Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 10/17/2018 10:28:12 AM - Followers: 196 - Board type: Free - Posts Today: 0

Apricus Biosciences, Inc. (APRI) 

 

 

http://www.apricusbio.com/

 

 

 

 

Company Address:

11975 El Camino Real, Suite 300
San Diego, CA 92130
T (858) 222-8041

 CIK:   0001017491

Apricus Website:    http://www.apricusbio.com/index.html

 

 
 

NexACT® - Multi-Route Drug Delivery Technology

NexACT® Multi-Route drug delivery technology facilitates compounds crossing the lipid bilayer and yet biodegrades in vivo to natural amino acids and natural fatty acids.

This technology is useful for:
  • Penetrating, proprietary, topical & transdermal formulations.
    Improving oral bioavailability of poorly soluble, poorly permeating compounds (BCS class 2-4)
    Delivering siRNA therapeutics into the cells; in vivo validated
    Development of more effective, penetrating cosmeceutic formulations
    Preservative

The safety and permeation properties of this proprietary drug delivery technology was demonstrated in the Vitaros® product which was approved for the treatment of erectile dysfunction in November 2010 by Health Canada, and approved by the European Union in June 2013.  Vitaros has been launched in all European Union countries by partner pharmaceutical companies.  Additional agreements for marketing Vitaros have been established.  For more information see the company's most recent 10K SEC filing.

In September 2015 the company anounced an agreement with Allergan to reacquire marketing rights for Vitaros in the U.S.  The company expects to resubmit a filing for FDA approval of Vitaros in the second half of 2016.  For more information see the company's most recent 10K SEC filing.


The company expects to initiate a Phase IIb clinical trial for RayVa to treat Reynaud's Syndrome in the second half of 2016.

In October 2014, the company acquired U.S. development and licensing rights to Fispemifene, a Selective Estrogen-Receptor Modulator (SERM) for treatment of secondary hypogonadism.  In March 2016 the company discontinued development Fispemifene after disappointing Phase IIb results.
.

 Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001017491&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Share Structure:
Outstanding Shares
 61,78M

Authorized Shares
75,000,000
  

Investor Relations:
ir@apricusbio.com
Tel: +1-858 222-8041

Matthew Beck
The Trout Group
:(646)378 2933

 

 

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 


                                                                           
Image result for vitaros                                                  

Image result for vitaros

High Times
APRI
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
APRI News: Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) 10/17/2018 06:03:34 AM
APRI News: Current Report Filing (8-k) 10/17/2018 06:03:33 AM
APRI News: Current Report Filing (8-k) 10/10/2018 06:05:20 AM
APRI News: Statement of Beneficial Ownership (sc 13d) 09/27/2018 04:33:56 PM
APRI News: Initial Statement of Beneficial Ownership (3) 09/27/2018 04:28:19 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#28096   You will need a lawyer. https://ih.advfn.com/p.php?pid=nmona&article=78479 mecosmo2 10/17/18 10:28:11 AM
#28095   Do you know if they announced anything in Rodney213 09/30/18 08:35:06 AM
#28094   Armistice Capital, Llc has filed a new activist Aprilov 09/27/18 09:04:00 PM
#28093   https://stocktwits.com/risenhoover/message/139125378 Aprilov 09/27/18 09:02:15 PM
#28092   Nice POP today. bigblue72 09/12/18 09:19:00 AM
#28091   Movement going final hours , more volume in Timing101 09/12/18 07:42:17 AM
#28090   I'm having a hard time feeling sorry for him!!!! oldcoach19 09/01/18 10:26:24 AM
#28089   Item 5.02. Departure of mecosmo2 09/01/18 10:03:52 AM
#28088   Apricus Biosciences beats by $0.02 mecosmo2 08/10/18 08:34:22 AM
#28087   Same here 70k shares ..... Seelos is backed Aprilov 08/07/18 08:12:28 AM
#28086   MG,I have the exact situation as you. Might oldcoach19 08/07/18 07:10:17 AM
#28085   Old Coach I am about 98% down for mean gene 08/06/18 05:37:04 PM
#28084   Ligand Licenses Four Programs to Seelos Therapeutics mecosmo2 08/05/18 10:37:25 AM
#28083   seelos pipeline , If this is accurate,. . mecosmo2 08/05/18 10:17:00 AM
#28082   Mean Gene,Are you sticking around to find out oldcoach19 08/01/18 04:02:22 PM
#28081   Thanks for your response, I would like a mecosmo2 08/01/18 11:29:55 AM
#28080   It does not matter what the price per mean gene 08/01/18 10:40:52 AM
#28079   The BIG question is. . At what price mecosmo2 08/01/18 10:13:58 AM
#28078   Apricus Biosciences, Inc. Announces Merger Agreement with Seelos mecosmo2 07/31/18 08:14:59 AM
#28077   "Subject to the terms and conditions of the north40000 07/30/18 03:54:13 PM
#28076   There is no mentions of R/S Detox33 07/30/18 09:57:05 AM
#28075   * is how they will be on the Nasdaq S3lfMade 07/30/18 08:50:26 AM
#28074   R/S is they will be on Nasdaq. Clearly S3lfMade 07/30/18 08:49:31 AM
#28073   When the merger is complete it will trade mecosmo2 07/30/18 08:44:11 AM
#28072   Apricus Biosciences, Inc. Announces Merger Agreement with Seelos mecosmo2 07/30/18 08:25:23 AM
#28071   $APRI this company is been going though restructuring Detox33 06/28/18 06:47:18 PM
#28070   ?? maybe Pascoe got lucky .... Aprilov 06/20/18 06:45:46 AM
#28069   * * $APRI Video Chart 06-19-18 * * ClayTrader 06/19/18 04:54:59 PM
#28068   Volume! Hold. aristotelisonassis 06/19/18 03:38:28 PM
#28067   long here. aristotelisonassis 06/19/18 02:59:42 PM
#28066   Share price going up to over $1.00 by Detox33 06/19/18 02:28:03 PM
#28065   * * $APRI Video Chart 06-12-18 * * ClayTrader 06/12/18 05:13:41 PM
#28064   .25 and off to the races ! CarlCarlMcB 06/12/18 09:48:04 AM
#28063   UP 12% premarket already news coming ? hebbeke47 06/12/18 05:46:06 AM
#28062   It may be a pump if so please Detox33 06/11/18 06:24:11 PM
#28061   * * $APRI Video Chart 06-11-18 * * ClayTrader 06/11/18 04:18:35 PM
#28060   There is no FDA NEWS Coming. The company Aprilov 06/11/18 04:05:11 PM
#28059   maybe positive FDA news coming soon. Holding tight overnight. aristotelisonassis 06/11/18 03:47:36 PM
#28058   Any news causing breakout Detox33 06/11/18 03:20:05 PM
#28057   breakout! Long. aristotelisonassis 06/11/18 02:25:45 PM
#28056   Item 5.07 Submission of Matters to a Vote mecosmo2 05/18/18 09:48:00 AM
#28055   1.50.. maybe Aprilov 05/16/18 12:23:38 PM
#28054   A buyout of $5.00 per share would be mecosmo2 05/16/18 12:22:24 PM
#28053   Apricus will either merge or be bought out Aprilov 05/15/18 04:52:00 PM
#28052   $1.21 by next week Detox33 05/15/18 04:12:58 PM
#28051   Picking up some today.. Like the way this #1pennytrader 05/15/18 11:14:34 AM
#28050   .08 coming CarlCarlMcB 05/14/18 01:01:45 PM
#28049   Very good news coming very soon on that front. cecilburrow 05/14/18 12:14:28 PM
#28048   Whats up? Possible sale or Partner? mecosmo2 05/11/18 01:00:25 PM
#28047   SAN DIEGO, May 03, 2018 (GLOBE NEWSWIRE) -- mecosmo2 05/04/18 08:17:00 AM
PostSubject